Foster & Motley Inc. Makes New $7.17 Million Investment in MetLife, Inc. $MET

Foster & Motley Inc. bought a new position in MetLife, Inc. (NYSE:MET) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 84,696 shares of the financial services provider’s stock, valued at approximately $7,166,000.

A number of other institutional investors have also recently added to or reduced their stakes in MET. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in shares of MetLife during the second quarter worth approximately $26,000. Alpine Woods Capital Investors LLC bought a new position in shares of MetLife during the second quarter valued at approximately $3,474,000. Meeder Advisory Services Inc. acquired a new position in shares of MetLife during the second quarter valued at $1,578,000. Tiemann Investment Advisors LLC bought a new position in MetLife in the 2nd quarter worth about $195,000. Finally, Pzena Investment Management LLC acquired a new stake in MetLife in the 2nd quarter valued at approximately $941,792,000. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Price Performance

Shares of MET stock opened at $96.83 on Wednesday. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. The firm has a market cap of $62.31 billion, a price-to-earnings ratio of 18.55, a PEG ratio of 0.75 and a beta of 0.78. The stock has a 50-day moving average price of $92.00 and a 200 day moving average price of $81.86. MetLife, Inc. has a 12 month low of $67.33 and a 12 month high of $100.93.

MetLife (NYSE:MET) last announced its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.30 by $0.13. The firm had revenue of $13.52 billion for the quarter, compared to analysts’ expectations of $19.67 billion. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The business’s revenue for the quarter was up 10.5% on a year-over-year basis. During the same period last year, the firm earned $2.02 earnings per share. Research analysts expect that MetLife, Inc. will post 9.7 EPS for the current year.

MetLife Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 8th. Investors of record on Tuesday, August 4th will be paid a dividend of $0.5925 per share. The ex-dividend date of this dividend is Tuesday, August 4th. This represents a $2.37 annualized dividend and a yield of 2.4%. MetLife’s dividend payout ratio (DPR) is presently 45.40%.

MetLife declared that its Board of Directors has initiated a stock buyback plan on Wednesday, August 5th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the financial services provider to repurchase up to 4.8% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board believes its shares are undervalued.

Wall Street Analyst Weigh In

Several research firms have issued reports on MET. Jefferies Financial Group boosted their price objective on MetLife from $97.00 to $103.00 and gave the stock a “buy” rating in a report on Friday, July 10th. Weiss Ratings upgraded shares of MetLife from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday, June 15th. Wells Fargo & Company upped their target price on shares of MetLife from $95.00 to $101.00 and gave the company an “overweight” rating in a research note on Thursday, July 9th. UBS Group lifted their price objective on MetLife from $102.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 8th. Finally, Wall Street Zen cut shares of MetLife from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, MetLife currently has an average rating of “Moderate Buy” and a consensus price target of $101.07.

Key Stories Impacting MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: DOWLING & PARTN raised its fiscal 2027 earnings estimate for MetLife to $10.85 per share from $10.75. The revision suggests improving analyst expectations for the insurer’s future profitability and is favorable for MET, although the new estimate remains above the broader current-year consensus of $9.70. MetLife FY2027 earnings estimate
• Neutral Sentiment: MetLife declared third-quarter 2026 dividends on several series of preferred stock, including Series A, Series D, Series E and Series F. The payments reinforce the company’s ongoing capital-return commitments, but they primarily affect preferred shareholders and are unlikely to materially change the valuation of MET common shares. MetLife preferred stock dividends
• Neutral Sentiment: MetLife published its 2025 sustainability report, highlighting research and insights related to its environmental, social and governance initiatives. The report may support the company’s long-term reputation with stakeholders, but it is not expected to have an immediate earnings impact. MetLife 2025 sustainability report
• Neutral Sentiment: Several headlines concern MetLife Stadium, including a new stadium CEO, rapid transitions between Jets and Giants games, and upcoming concerts. These stories relate to the sports and entertainment venue—not MetLife, Inc.’s insurance and financial-services operations—and should not materially affect MET stock. MetLife Stadium names new CEO

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.